Announcement Össur hf. No. 19/2012
Reykjavik, 23 May 2012
New R&D leadership
Dr. Hilmar B. Janusson, EVP of Research & Development (R&D), has decided to take
on new challenges to pursue his interst in the academic field and take on the
role of Dean of School of Engineering and Natural Sciences at the University of
Iceland. Hilmar will continue to support R&D as a long term consultant.
Dr. Thorvaldur Ingvarsson has been appointed EVP of R&D and will become a member
of the Össur Executive Committee. Thorvaldur joined Össur in 2009 as Medical
Officer, contributing greatly to the clinical research efforts and product
design based on medical necessity, which is an increasingly important part of
the medical device R&D process. Thorvaldur holds a PhD degree from the
University of Lund in Sweden, with emphasises on osteoarthritis and health
economic outcomes, he has 19 years of experience as an orthopaedic surgeon.
Prior to joining Össur he has held a medical director position as well as a CEO
position within the hospital setting. Thorvaldur has published more than 40
scientific papers and is currently involved in international research projects
related to osteoarthritis, ligament healing, health economics outcomes and
biomechanics of prostheses.
These management changes will become effective as of June 30(th).
Jón Sigurðsson, President & CEO, comments:
"Thorvaldur Ingvarsson brings with him a wealth of expertise and experience in
the field to lead a dedicated team to further advance our technological platform
and clinical research. For more than 20 years Hilmar has been an instrumental
force in establishing Össur as a technology leader in the market. On behalf of
all Össur employees I thank him for his valuable contribution to our Company."
Össur (NASDAQ OMX: OSSR) is a global leader in non-invasive orthopaedics that
help people live a life without limitations. Its business is focused on
improving people's mobility through the delivery of innovative technologies
within the fields of braces, supports, prosthetic limbs and compression
therapy, including the Flex-Foot Cheetah carbon fiber running prostheses used by
"The Blade Runner," renowned double-amputee sprinter Oscar Pistorius. A
recognized "Technology Pioneer", Össur invests significantly in research and
product development; its award-winning designs ensuring a consistently strong
position in the market. Successful patient and clinical outcomes are further
empowered via Össur's educational programs and business solutions.
Headquartered in Iceland, Össur has major operations in the Americas, Europe and
Asia, with additional distributors worldwide. www.ossur.com